市場調査レポート

商品コード

1318684

神経痛治療市場：治療法、適応症、流通チャネル別-2023-2030年の世界予測

Neuralgia Treatment Market by Treatment, Indication, Distribution Channel - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030

出版日: 2023年06月12日 | 発行: 360iResearch

| ページ情報: 英文 181 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　詳細はお問い合わせください。

価格

PDF, Excel & Online Access - 1 Year (Single User License)

USD 4,749 746,257円

レポートPDF及びExcelを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。購入後1年間、レポートにオンラインでアクセス可能です。

PDF, Excel & Online Access - 1 Year (Up to 5 User License)

USD 5,749 903,397円

レポートPDF及びExcelを5名まで共有ご利用頂けるライセンスです。ご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。購入後1年間、レポートにオンラインでアクセス可能です。

PDF, Excel & Online Access - 1 Year (Site License)

USD 6,749 1,060,537円

レポートPDF及びExcelを同一事業所（所在地）内のすべての方でご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。購入後1年間、レポートにオンラインでアクセス可能です。

PDF, Excel & Online Access - 1 Year (Enterprise User License)

USD 8,749 1,374,817円

レポートPDF及びExcelを同一企業の全世界の方にご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。購入後1年間、レポートにオンラインでアクセス可能です。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=157.14円

ご注意事項 :

本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

神経痛治療の世界市場は、2023年にはCAGR 12.39%で10億6,895万米ドルと予測され、2030年には24億2,577万米ドルと驚異的な成長を遂げると予測されています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは世界の神経痛治療市場を評価するために不可欠です。事業戦略と製品満足度の主要指標を調査することで、ベンダーの包括的な評価を提供し、ユーザーは特定のニーズに基づいた情報をもとに意思決定を行うことができます。この高度な分析により、ベンダーは成功の度合いが異なる4つの象限に整理されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析では、特定の市場領域におけるベンダーの現状を洞察することができます。全体的な収益、顧客基盤、その他の主要指標に対するベンダーの貢献度を比較することで、企業が市場シェアを争う際に、自社の業績や直面している状況をより深く理解することができます。また、本分析では、調査した基準年において、特定のセクターがどの程度競合しているのか、蓄積、断片化の優位性、合併の特徴についても明らかにしています。

本レポートは、以下のポイントに関する洞察を提供します：

1.市場の浸透度：主要企業が提供する市場に関する包括的な情報を提供します。

2.市場の発展：有利な新興市場に関する詳細情報を提供し、市場の成熟セグメントにおける浸透度を分析します。

3.市場の多様化：新製品の上市、未開発地域、最近の開発、投資に関する詳細情報を提供します。

4.市場の動向：COVID-19、ロシア・ウクライナ紛争、高インフレの累積的な影響を包括的に理解することができます。

5.競合の評価と情報：主要企業の市場シェア、戦略、製品、認証、規制状況、特許状況、製造能力を網羅的に評価します。

6.製品開発およびイノベーション：将来技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような質問にお答えします：

1.神経痛治療の世界市場規模および予測は？

2.予測期間中、世界の神経痛治療市場を形成するCOVID-19の阻害要因と影響は？

3.神経痛治療の世界市場において予測期間中に投資すべき製品/セグメント/アプリケーション/分野は？

4.神経痛治療の世界市場における競争戦略は？

5.神経痛治療の世界市場における技術動向と規制の枠組みは？

6.神経痛治療の世界市場における主要ベンダーの市場シェアは？

7.神経痛治療の世界市場への参入には、どのような形態や戦略的な動きが適していると考えられるか？

市場力学
- 促進要因
  - 高齢化の進展により神経痛が増加
  - 神経痛治療製品に関する認識を広める政府の取り組み
- 抑制要因
  - 神経痛の治療には高額な費用がかかる
- 機会
  - 技術の進歩により薬や手術の必要性がなくなる
  - 新興経済諸国における外科的および薬物療法の開発
- 課題
  - 薬による持続的な副作用
市場動向
COVID-19の累積的な影響
ロシア・ウクライナ紛争の累積的影響
高インフレの累積的影響
ポーターのファイブフォース分析
バリューチェーンとクリティカルパス分析
規制の枠組み
顧客のカスタマイズ
- 規制の枠組み

第6章神経痛治療市場治療別

薬物ベース
- 抗けいれん薬
- 三環系抗うつ薬
手術
- バルーン圧縮
- グリセロール注射
- 微小血管減圧術
- 高周波熱損傷
- 定位放射線手術

第7章神経痛治療市場適応症別

糖尿病性神経障害
肋間神経痛
後頭神経痛
末梢神経痛
帯状疱疹後神経痛
三叉神経痛

第8章神経痛治療市場：流通チャネル別

ドラッグストア
病院薬局
オンライン薬局
小売薬局

第9章南北アメリカの神経痛治療市場

アルゼンチン
ブラジル
カナダ
メキシコ
米国

第10章アジア太平洋地域の神経痛治療市場

オーストラリア
中国
インド
インドネシア
日本
マレーシア
フィリピン
シンガポール
韓国
台湾
タイ
ベトナム

第11章欧州・中東・アフリカの神経痛治療市場

デンマーク
エジプト
フィンランド
フランス
ドイツ
イスラエル
イタリア
オランダ
ナイジェリア
ノルウェー
ポーランド
カタール
ロシア
サウジアラビア
南アフリカ
スペイン
スウェーデン
スイス
トルコ
アラブ首長国連邦
英国

第12章競合情勢

FPNVポジショニングマトリクス
市場シェア分析：主要企業別
競合シナリオ分析：主要企業別

第13章掲載企業一覧

第14章付録

ディスカッションガイド
ライセンスと価格について

図表

LIST OF FIGURES

FIGURE 1. NEURALGIA TREATMENT MARKET RESEARCH PROCESS
FIGURE 2. NEURALGIA TREATMENT MARKET SIZE, 2022 VS 2030
FIGURE 3. NEURALGIA TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT, 2022 VS 2030 (%)
FIGURE 5. NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2022 VS 2030 (%)
FIGURE 6. NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2022 VS 2030 (%)
FIGURE 7. NEURALGIA TREATMENT MARKET SIZE, BY REGION, 2022 VS 2030 (%)
FIGURE 8. NEURALGIA TREATMENT MARKET DYNAMICS
FIGURE 9. NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 10. NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 11. NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 12. AMERICAS NEURALGIA TREATMENT MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 13. UNITED STATES NEURALGIA TREATMENT MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 14. ASIA-PACIFIC NEURALGIA TREATMENT MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 15. EUROPE, MIDDLE EAST & AFRICA NEURALGIA TREATMENT MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 16. NEURALGIA TREATMENT MARKET, FPNV POSITIONING MATRIX, 2022
FIGURE 17. NEURALGIA TREATMENT MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

TABLE 1. NEURALGIA TREATMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
TABLE 3. NEURALGIA TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 5. NEURALGIA TREATMENT MARKET SIZE, BY DRUG-BASED, 2018-2030 (USD MILLION)
TABLE 6. NEURALGIA TREATMENT MARKET SIZE, BY DRUG-BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. NEURALGIA TREATMENT MARKET SIZE, BY ANTICONVULSANT MEDICINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. NEURALGIA TREATMENT MARKET SIZE, BY TRICYCLIC ANTIDEPRESSANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. NEURALGIA TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 10. NEURALGIA TREATMENT MARKET SIZE, BY SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. NEURALGIA TREATMENT MARKET SIZE, BY BALLOON COMPRESSION, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. NEURALGIA TREATMENT MARKET SIZE, BY GLYCEROL INJECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. NEURALGIA TREATMENT MARKET SIZE, BY MICROVASCULAR DECOMPRESSION, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. NEURALGIA TREATMENT MARKET SIZE, BY RADIOFREQUENCY THERMAL LESIONING, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. NEURALGIA TREATMENT MARKET SIZE, BY STEREOTACTIC RADIOSURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 17. NEURALGIA TREATMENT MARKET SIZE, BY DIABETIC NEUROPATHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. NEURALGIA TREATMENT MARKET SIZE, BY INTERCOSTAL NEURALGIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. NEURALGIA TREATMENT MARKET SIZE, BY OCCIPITAL NEURALGIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. NEURALGIA TREATMENT MARKET SIZE, BY PERIPHERAL NEURALGIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. NEURALGIA TREATMENT MARKET SIZE, BY POSTHERPETIC NEURALGIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. NEURALGIA TREATMENT MARKET SIZE, BY TRIGEMINAL NEURALGIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 24. NEURALGIA TREATMENT MARKET SIZE, BY DRUG STORES, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. NEURALGIA TREATMENT MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. NEURALGIA TREATMENT MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. NEURALGIA TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. AMERICAS NEURALGIA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 29. AMERICAS NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 30. AMERICAS NEURALGIA TREATMENT MARKET SIZE, BY DRUG-BASED, 2018-2030 (USD MILLION)
TABLE 31. AMERICAS NEURALGIA TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 32. AMERICAS NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 33. AMERICAS NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 34. ARGENTINA NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 35. ARGENTINA NEURALGIA TREATMENT MARKET SIZE, BY DRUG-BASED, 2018-2030 (USD MILLION)
TABLE 36. ARGENTINA NEURALGIA TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 37. ARGENTINA NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 38. ARGENTINA NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 39. BRAZIL NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 40. BRAZIL NEURALGIA TREATMENT MARKET SIZE, BY DRUG-BASED, 2018-2030 (USD MILLION)
TABLE 41. BRAZIL NEURALGIA TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 42. BRAZIL NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 43. BRAZIL NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 44. CANADA NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 45. CANADA NEURALGIA TREATMENT MARKET SIZE, BY DRUG-BASED, 2018-2030 (USD MILLION)
TABLE 46. CANADA NEURALGIA TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 47. CANADA NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 48. CANADA NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 49. MEXICO NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 50. MEXICO NEURALGIA TREATMENT MARKET SIZE, BY DRUG-BASED, 2018-2030 (USD MILLION)
TABLE 51. MEXICO NEURALGIA TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 52. MEXICO NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 53. MEXICO NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 54. UNITED STATES NEURALGIA TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES NEURALGIA TREATMENT MARKET SIZE, BY DRUG-BASED, 2018-2030 (USD MILLION)
TABLE 57. UNITED STATES NEURALGIA TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 58. UNITED STATES NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 59. UNITED STATES NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 60. ASIA-PACIFIC NEURALGIA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 61. ASIA-PACIFIC NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 62. ASIA-PACIFIC NEURALGIA TREATMENT MARKET SIZE, BY DRUG-BASED, 2018-2030 (USD MILLION)
TABLE 63. ASIA-PACIFIC NEURALGIA TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 64. ASIA-PACIFIC NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 65. ASIA-PACIFIC NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 66. AUSTRALIA NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 67. AUSTRALIA NEURALGIA TREATMENT MARKET SIZE, BY DRUG-BASED, 2018-2030 (USD MILLION)
TABLE 68. AUSTRALIA NEURALGIA TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 69. AUSTRALIA NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 70. AUSTRALIA NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 71. CHINA NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 72. CHINA NEURALGIA TREATMENT MARKET SIZE, BY DRUG-BASED, 2018-2030 (USD MILLION)
TABLE 73. CHINA NEURALGIA TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 74. CHINA NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 75. CHINA NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 76. INDIA NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 77. INDIA NEURALGIA TREATMENT MARKET SIZE, BY DRUG-BASED, 2018-2030 (USD MILLION)
TABLE 78. INDIA NEURALGIA TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 79. INDIA NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 80. INDIA NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 81. INDONESIA NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 82. INDONESIA NEURALGIA TREATMENT MARKET SIZE, BY DRUG-BASED, 2018-2030 (USD MILLION)
TABLE 83. INDONESIA NEURALGIA TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 84. INDONESIA NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 85. INDONESIA NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 86. JAPAN NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 87. JAPAN NEURALGIA TREATMENT MARKET SIZE, BY DRUG-BASED, 2018-2030 (USD MILLION)
TABLE 88. JAPAN NEURALGIA TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 89. JAPAN NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 90. JAPAN NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 91. MALAYSIA NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 92. MALAYSIA NEURALGIA TREATMENT MARKET SIZE, BY DRUG-BASED, 2018-2030 (USD MILLION)
TABLE 93. MALAYSIA NEURALGIA TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 94. MALAYSIA NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 95. MALAYSIA NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 96. PHILIPPINES NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 97. PHILIPPINES NEURALGIA TREATMENT MARKET SIZE, BY DRUG-BASED, 2018-2030 (USD MILLION)
TABLE 98. PHILIPPINES NEURALGIA TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 99. PHILIPPINES NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 100. PHILIPPINES NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 101. SINGAPORE NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 102. SINGAPORE NEURALGIA TREATMENT MARKET SIZE, BY DRUG-BASED, 2018-2030 (USD MILLION)
TABLE 103. SINGAPORE NEURALGIA TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 104. SINGAPORE NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 105. SINGAPORE NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 106. SOUTH KOREA NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 107. SOUTH KOREA NEURALGIA TREATMENT MARKET SIZE, BY DRUG-BASED, 2018-2030 (USD MILLION)
TABLE 108. SOUTH KOREA NEURALGIA TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 109. SOUTH KOREA NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 110. SOUTH KOREA NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 111. TAIWAN NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 112. TAIWAN NEURALGIA TREATMENT MARKET SIZE, BY DRUG-BASED, 2018-2030 (USD MILLION)
TABLE 113. TAIWAN NEURALGIA TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 114. TAIWAN NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 115. TAIWAN NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 116. THAILAND NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 117. THAILAND NEURALGIA TREATMENT MARKET SIZE, BY DRUG-BASED, 2018-2030 (USD MILLION)
TABLE 118. THAILAND NEURALGIA TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 119. THAILAND NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 120. THAILAND NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 121. VIETNAM NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 122. VIETNAM NEURALGIA TREATMENT MARKET SIZE, BY DRUG-BASED, 2018-2030 (USD MILLION)
TABLE 123. VIETNAM NEURALGIA TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 124. VIETNAM NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 125. VIETNAM NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 126. EUROPE, MIDDLE EAST & AFRICA NEURALGIA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 127. EUROPE, MIDDLE EAST & AFRICA NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 128. EUROPE, MIDDLE EAST & AFRICA NEURALGIA TREATMENT MARKET SIZE, BY DRUG-BASED, 2018-2030 (USD MILLION)
TABLE 129. EUROPE, MIDDLE EAST & AFRICA NEURALGIA TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 130. EUROPE, MIDDLE EAST & AFRICA NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 131. EUROPE, MIDDLE EAST & AFRICA NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 132. DENMARK NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 133. DENMARK NEURALGIA TREATMENT MARKET SIZE, BY DRUG-BASED, 2018-2030 (USD MILLION)
TABLE 134. DENMARK NEURALGIA TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 135. DENMARK NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 136. DENMARK NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 137. EGYPT NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 138. EGYPT NEURALGIA TREATMENT MARKET SIZE, BY DRUG-BASED, 2018-2030 (USD MILLION)
TABLE 139. EGYPT NEURALGIA TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 140. EGYPT NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 141. EGYPT NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 142. FINLAND NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 143. FINLAND NEURALGIA TREATMENT MARKET SIZE, BY DRUG-BASED, 2018-2030 (USD MILLION)
TABLE 144. FINLAND NEURALGIA TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 145. FINLAND NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 146. FINLAND NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 147. FRANCE NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 148. FRANCE NEURALGIA TREATMENT MARKET SIZE, BY DRUG-BASED, 2018-2030 (USD MILLION)
TABLE 149. FRANCE NEURALGIA TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 150. FRANCE NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 151. FRANCE NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 152. GERMANY NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 153. GERMANY NEURALGIA TREATMENT MARKET SIZE, BY DRUG-BASED, 2018-2030 (USD MILLION)
TABLE 154. GERMANY NEURALGIA TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 155. GERMANY NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 156. GERMANY NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 157. ISRAEL NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 158. ISRAEL NEURALGIA TREATMENT MARKET SIZE, BY DRUG-BASED, 2018-2030 (USD MILLION)
TABLE 159. ISRAEL NEURALGIA TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 160. ISRAEL NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 161. ISRAEL NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 162. ITALY NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 163. ITALY NEURALGIA TREATMENT MARKET SIZE, BY DRUG-BASED, 2018-2030 (USD MILLION)
TABLE 164. ITALY NEURALGIA TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 165. ITALY NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 166. ITALY NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 167. NETHERLANDS NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 168. NETHERLANDS NEURALGIA TREATMENT MARKET SIZE, BY DRUG-BASED, 2018-2030 (USD MILLION)
TABLE 169. NETHERLANDS NEURALGIA TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 170. NETHERLANDS NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 171. NETHERLANDS NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 172. NIGERIA NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 173. NIGERIA NEURALGIA TREATMENT MARKET SIZE, BY DRUG-BASED, 2018-2030 (USD MILLION)
TABLE 174. NIGERIA NEURALGIA TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 175. NIGERIA NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 176. NIGERIA NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 177. NORWAY NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 178. NORWAY NEURALGIA TREATMENT MARKET SIZE, BY DRUG-BASED, 2018-2030 (USD MILLION)
TABLE 179. NORWAY NEURALGIA TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 180. NORWAY NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 181. NORWAY NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 182. POLAND NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 183. POLAND NEURALGIA TREATMENT MARKET SIZE, BY DRUG-BASED, 2018-2030 (USD MILLION)
TABLE 184. POLAND NEURALGIA TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 185. POLAND NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 186. POLAND NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 187. QATAR NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 188. QATAR NEURALGIA TREATMENT MARKET SIZE, BY DRUG-BASED, 2018-2030 (USD MILLION)
TABLE 189. QATAR NEURALGIA TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 190. QATAR NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 191. QATAR NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 192. RUSSIA NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 193. RUSSIA NEURALGIA TREATMENT MARKET SIZE, BY DRUG-BASED, 2018-2030 (USD MILLION)
TABLE 194. RUSSIA NEURALGIA TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 195. RUSSIA NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 196. RUSSIA NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 197. SAUDI ARABIA NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 198. SAUDI ARABIA NEURALGIA TREATMENT MARKET SIZE, BY DRUG-BASED, 2018-2030 (USD MILLION)
TABLE 199. SAUDI ARABIA NEURALGIA TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 200. SAUDI ARABIA NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 201. SAUDI ARABIA NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 202. SOUTH AFRICA NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 203. SOUTH AFRICA NEURALGIA TREATMENT MARKET SIZE, BY DRUG-BASED, 2018-2030 (USD MILLION)
TABLE 204. SOUTH AFRICA NEURALGIA TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 205. SOUTH AFRICA NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 206. SOUTH AFRICA NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 207. SPAIN NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 208. SPAIN NEURALGIA TREATMENT MARKET SIZE, BY DRUG-BASED, 2018-2030 (USD MILLION)
TABLE 209. SPAIN NEURALGIA TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 210. SPAIN NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 211. SPAIN NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 212. SWEDEN NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 213. SWEDEN NEURALGIA TREATMENT MARKET SIZE, BY DRUG-BASED, 2018-2030 (USD MILLION)
TABLE 214. SWEDEN NEURALGIA TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 215. SWEDEN NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 216. SWEDEN NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 217. SWITZERLAND NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 218. SWITZERLAND NEURALGIA TREATMENT MARKET SIZE, BY DRUG-BASED, 2018-2030 (USD MILLION)
TABLE 219. SWITZERLAND NEURALGIA TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 220. SWITZERLAND NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 221. SWITZERLAND NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 222. TURKEY NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 223. TURKEY NEURALGIA TREATMENT MARKET SIZE, BY DRUG-BASED, 2018-2030 (USD MILLION)
TABLE 224. TURKEY NEURALGIA TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 225. TURKEY NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 226. TURKEY NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 227. UNITED ARAB EMIRATES NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 228. UNITED ARAB EMIRATES NEURALGIA TREATMENT MARKET SIZE, BY DRUG-BASED, 2018-2030 (USD MILLION)
TABLE 229. UNITED ARAB EMIRATES NEURALGIA TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 230. UNITED ARAB EMIRATES NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 231. UNITED ARAB EMIRATES NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 232. UNITED KINGDOM NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 233. UNITED KINGDOM NEURALGIA TREATMENT MARKET SIZE, BY DRUG-BASED, 2018-2030 (USD MILLION)
TABLE 234. UNITED KINGDOM NEURALGIA TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 235. UNITED KINGDOM NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 236. UNITED KINGDOM NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 237. NEURALGIA TREATMENT MARKET, FPNV POSITIONING MATRIX, 2022
TABLE 238. NEURALGIA TREATMENT MARKET SHARE, BY KEY PLAYER, 2022
TABLE 239. NEURALGIA TREATMENT MARKET LICENSE & PRICING

Product Code: MRR-F74E250AD649

The Global Neuralgia Treatment Market is forecasted to grow significantly, with a projected USD 1,068.95 million in 2023 at a CAGR of 12.39% and expected to reach a staggering USD 2,425.77 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Neuralgia Treatment Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Neuralgia Treatment Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Treatment, market is studied across Drug-Based and Surgery. The Drug-Based is further studied across Anticonvulsant Medicines and Tricyclic Antidepressants. The Surgery is further studied across Balloon Compression, Glycerol Injection, Microvascular Decompression, Radiofrequency Thermal Lesioning, and Stereotactic Radiosurgery. The Drug-Based is projected to witness significant market share during forecast period.

Based on Indication, market is studied across Diabetic Neuropathy, Intercostal Neuralgia, Occipital Neuralgia, Peripheral Neuralgia, Postherpetic Neuralgia, and Trigeminal Neuralgia. The Intercostal Neuralgia is projected to witness significant market share during forecast period.

Based on Distribution Channel, market is studied across Drug Stores, Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies. The Hospital Pharmacies is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.74% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Neuralgia Treatment Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Neuralgia Treatment Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Neuralgia Treatment Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Neuralgia Treatment Market?

4. What is the competitive strategic window for opportunities in the Global Neuralgia Treatment Market?

5. What are the technology trends and regulatory frameworks in the Global Neuralgia Treatment Market?

6. What is the market share of the leading vendors in the Global Neuralgia Treatment Market?

7. What modes and strategic moves are considered suitable for entering the Global Neuralgia Treatment Market?

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Neuralgia Treatment Market, by Treatment, 2022 vs 2030
4.3. Neuralgia Treatment Market, by Indication, 2022 vs 2030
4.4. Neuralgia Treatment Market, by Distribution Channel, 2022 vs 2030
4.5. Neuralgia Treatment Market, by Region, 2022 vs 2030

5. Market Insights

5.1. Market Dynamics
- 5.1.1. Drivers
  - 5.1.1.1. Increasing incidences of neuralgia due to the rise in the aging population
  - 5.1.1.2. Government initiatives to spread awareness regarding neuralgia treatment products
- 5.1.2. Restraints
  - 5.1.2.1. High-cost associated with the treatment of neuralgia
- 5.1.3. Opportunities
  - 5.1.3.1. Technological advancement eliminates the need for drugs and surgery
  - 5.1.3.2. Developing surgical and pharmacological treatment in developing economies
- 5.1.4. Challenges
  - 5.1.4.1. Persistent side effects from medications
5.2. Market Trends
5.3. Cumulative Impact of COVID-19
5.4. Cumulative Impact of Russia-Ukraine Conflict
5.5. Cumulative Impact of High Inflation
5.6. Porter's Five Forces Analysis
- 5.6.1. Threat of New Entrants
- 5.6.2. Threat of Substitutes
- 5.6.3. Bargaining Power of Customers
- 5.6.4. Bargaining Power of Suppliers
- 5.6.5. Industry Rivalry
5.7. Value Chain & Critical Path Analysis
5.8. Regulatory Framework
5.9. Client Customization
- 5.9.1. Regulatory Framework

6. Neuralgia Treatment Market, by Treatment

6.1. Introduction
6.2. Drug-Based
- 6.2.1. Anticonvulsant Medicines
- 6.2.2. Tricyclic Antidepressants
6.3. Surgery
- 6.3.1. Balloon Compression
- 6.3.2. Glycerol Injection
- 6.3.3. Microvascular Decompression
- 6.3.4. Radiofrequency Thermal Lesioning
- 6.3.5. Stereotactic Radiosurgery

7. Neuralgia Treatment Market, by Indication

7.1. Introduction
7.2. Diabetic Neuropathy
7.3. Intercostal Neuralgia
7.4. Occipital Neuralgia
7.5. Peripheral Neuralgia
7.6. Postherpetic Neuralgia
7.7. Trigeminal Neuralgia

8. Neuralgia Treatment Market, by Distribution Channel

8.1. Introduction
8.2. Drug Stores
8.3. Hospital Pharmacies
8.4. Online Pharmacies
8.5. Retail Pharmacies

9. Americas Neuralgia Treatment Market

9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Neuralgia Treatment Market

10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam

11. Europe, Middle East & Africa Neuralgia Treatment Market

11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom

神経痛治療市場：治療法、適応症、流通チャネル別-2023-2030年の世界予測

Neuralgia Treatment Market by Treatment, Indication, Distribution Channel - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030

FPNVポジショニング・マトリックス

市場シェア分析

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

第6章 神経痛治療市場治療別

第7章 神経痛治療市場適応症別

第8章 神経痛治療市場：流通チャネル別

第9章 南北アメリカの神経痛治療市場

第10章 アジア太平洋地域の神経痛治療市場

第11章 欧州・中東・アフリカの神経痛治療市場

第12章 競合情勢

第13章 掲載企業一覧

第14章 付録